Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Articles
DOI: 10.1055/s-0040-1705639
Submitted: 02-07-2022
Published: 02-07-2022

A importância do magnésio na doença cardiovascular

Médica Cardiologista
Magnesium cardiovascular diseases diabetes arterial hypertension myocardial infarction/complications magnesium deficiency/etiology cardiac failure/complications

Abstract

This paper is a literature review that aimed at describing the importance of magnesium in cardiovascular disease. Bibliographic compilations about original scientific articles and literature reviews on indexed journals were carried out. The work has described that magnesium ion is involved in over 300 enzymatic reactions with anti-inflammatory, anti-oxidant and cell growth modulating properties in order to reduce oxidative stress. Magnesium deficiency is associated to metabolic syndrome, hypertension, congestive heart failure, diabetes mellitus and arrhythmias. It has been concluded that magnesium, because of its role of relaxing the smooth muscles of cardiac vessels, dilates the coronary arteries improving myocardial contractility, reducing the risks of coronary spasms and inhibiting platelet aggregation by increasing the relationship between prostacyclin/ thromboxane. Due to its dilating effect, it reduces blood pressure and is responsible for stabilizing the cardiac rhythm. Therefore, it plays an important role in cardiovascular diseases’.

Metrics

Metrics Loading ...

References

  1. Lenfant C. Can we prevent cardiovascular diseases in low and middle-income countries? Bull World Health Organ. 2001; 79:980-2.
  2. Laurenti R, Lolio CA. Cardiopatia isquêmica no Brasil. Considerações epidemiológicas. In: Carvalho VB, Macroz R. Cardiopatia isquêmica – aspectos de importância clínica. 1. ed. São Paulo: Savier, 1989.
  3. Herzog WR, Atar D, Mak IT, Alyono D, MacCord C, Weglicki WB - Magnesium deficiency prolongs myocardial stunning in an open-chest swine model. Int J Cardiol 1994; 47: 105-15.
  4. Satur CMR, Anderson J R, Jennings A, Newton K, Martin PG, Nair U, Walker DR. Magnesium flux caused by coronary artery bypass operation: three patterns of deficiency. Ann Thorac Surg 1994; 58: 1674-8.
  5. Caspi J, Rudis E, Bar I, Safadi T, Saute M - Effects of magnesium on myocardial function after coronary artery bypass grafting. Ann Thorac Surg 1995; 59: 942-7.
  6. Aziz S, Haigh WG, Van Norman GA, Kenny RJ, Kenny MA - Blood ionized magnesium concentrations during cardiopulmonary bypass and their correlation with other circulating cations. J Card Surg 1996; 11: 341-7.
  7. Altura BT & Altura BM - Endothelium-dependent relaxation in coronary arteries requires magnesium ions. Br J Pharmacol 1987; 91: 449-51. - 8.
  8. Pearson PJ, Evora PR, Seccombe JF, Schaff HV Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations. Ann Thorac Surg 1998; 65: 967-72.
  9. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardo A, Paolisso G. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med. 2003;24: 39 –52
  10. Beyenbach, K.W: The physiology of intracellular magnesium. In: Magnesium and Physical Activity, Ed: Vecchiet L., The Parthenon Publishing Group, New-York, pp. 93-116 (1995).
  11. He K, Liu K, Daviglus ML et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation, 2006; 113(13):1675-82.
  12. Bo S, Pisu E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Current opinion in lipidology.2008; 19 (1):50-6.
  13. Chacko SA, Song Y, Nathan L, Tinker L et al. Relations of dietary magnesimn intake to biomarkers of inflarrunation and endothelial dysftmction in an etlmically diverse cohort of postmenopausal women. Diabetes care. 2009; 33(2):304-10.
  14. Durlach, J & M. Bara: Le Magnésium en Biologie et em Médecine. Editions médicales internationales, 2nd ed., Cachan, França (2000).
  15. Gilbert D’Angelo et al. Magnesium relaxes arterial smooth muscle by dcreasing intracellular Ca+2 without changing intracellular Mg+2. J Clin Invest, v.89, p.1988-1994, 1992.
  16. McLean R.M. Magnesium and its therapeutic uses: a review. v. 96. The American Journal of Medicine, jan, 1994.
  17. Oliveira FLC, Escrivão MAMS. Osteoporose. In Lopes FA, Brasil ALD. Nutrição e dietética em clínica pediátrica. São Paulo, 2003.
  18. Shils, Maurice E., Young, Wernon R. — Modern Nutrition in Health and Disease — 2.8 ed., pg. 159-188.
  19. Elin RJ. Laboratory tests for the assessment of magnesium status in humans. Magnes Trace Elem. 1991-1992;10(2-4):172-81.
  20. Arnauld MJ. Update on the assessment of magnesium status. Br J Nutr. 2008;99 (Suppl.3):S24-36.
  21. Almeida LC, Cardoso MA. Magnésio, Sódio e Potássio. In: Marly Augusto Cardoso. (Org.). Nutrição Humana. 1ª ed. Rio de Janeiro: Guanabara Koogan, 2006, p. 237-257.
  22. Bohl, C.H.; VOLPE, S.L. Magnesium and exercise. Critical Reviews in Food Science and Nutrition, v.42, n.6, p. 533-563, 2002.
  23. Alday Muñoz E, Una Orejón R, Redondo Calvo FJ et al. Magnesio en anestesia y reanimación. Rev Esp. Anestesiol Reanim 2005;52:222-234.
  24. Marino PL. Magnésio. In: Marino PL. Compêndio de UTI. Porto Alegre: Artmed, 2000;529-538)
  25. Brown B. History of magnesium production. Disponível em: <http://www.magnesium.com/w3/data bank/index.php?mgw=196>. Acesso em 8 abr. 2012.
  26. Duarte A.C. Semiologia Imunológica Nutricional. Rio de Janeiro: Axcel Books do Brasil, 2003.
  27. Basso LE, Ubbink JB, Delport R. Erythrocyte magnesium concentration as an index of mag nesium status: a perspective from a magnesium supplementation study. Clin Chim Acta 2000; 291(1):1 8
  28. Yu AS. Evolving concepts in epithelial magnesium transport. Curr Opin Nephrol Hypertens 2001; 10:649‑53.
  29. Blanchard A, Jeunemaitre X, Coudal P, Dechaux M, Froissart M, May A, Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 2001; 59(6):2206‑15.
  30. Konrad M, Weber S. Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 2003; 14(1):249‑60.
  31. Norès, J. M.; Rochette, L.; Bril, A.; Nenna, A. — Phisiologie du magnésium — Cah. Nutr. Dit., XXIII. 5(1988),379-384.
  32. Papadopol V, Tuchendria E, Palamaru I (2001) Magnesium and some psychological features in two groups of pupils (magnesium and psychic features). Magnes Res 14:27-32.
  33. Wacker WE, Parisi AF. Magnesium metabolism. N Engl J Med. 1968;278:712.
  34. Eby G. A., Eby K. L. Rapid recovery from major depression using magnesium treatment. Medical Hypotheses. 2006;67(2):362–370. doi: 10.1016/j.mehy.2006.01.047.
  35. Ohba, Sachiko, et al. “Metal ions affect neuronal membrane fluidity of rat cerebral cortex.” Neurochemical research 19.3 (1994): 237-241.
  36. BELIN RJ, He K. Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome. Magnes Res. 2007;20(2):107-29.
  37. Wirell MP, Wester PO, Stegmayr BG. Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind, cross-over study. J Intern Med. 1994;236(2):189-95.
  38. Sneddon, J.M: Divalent cations and the blood platelet release reaction. Nature Lond 236, 103-104 (1972).
  39. Mazur, A., Maier, J. A., Rock, E., Gueux, E., Nowacki, W., & Rayssiguier, Y. (2007). Magnesium and the inflammatory response: potential physiopathological implications. Archives of biochemistry and biophysics, 458(1), 48-56.
  40. Colli C, Sales CH, Rocha VS. Assessment of magnesium status. In: Berhardt LV (org.). Advances in medicine and biology. Hauppauge, Nova Science Publishers Inc 2012; 40:191-216.
  41. Rude RK, Singer FR, Gruber HE. Skeletal and hormonal effects of magnesium deficiency.J Am Coll Nutr 2009; 28(2):131‑41.
  42. Weglicki WB. Hypomagnesemia and inflammation: clinical and basic aspects. Annu Rev Nutr 2012; 32:4.1‑4.17 doi 10.1146/annurev‑nutr‑071811‑150656.
  43. Durlach, J: O magnésio na prática clínica. Ed: Durlach, J., John Libbey Eurotext, Paris, França (1988).
  44. Seelig, M.S: Os dados epidemiológicos sobre magnésio doença cardiovascular e osteoporose associada à deficiência de: consideração dos riscos de recomendações atuais para alta ingestão de cálcio. In: Avanços na pesquisa de magnésio. Nutrição e Saúde. Eds: Rayssiguier, Y., A. Mazur, J. Durlach, John Libbey & Company Ltd., Londres, Reino Unido, pp. 177- 190 (de 2001);
  45. Rayssiguier, Y, C. Malpuech, W. Nowacki, E. Rock, E. Gueux: & A. Mazur: A resposta inflamatória em A deficiência de magnésio. In: Avanços em magnésio Pesquisa: 1 Magnésio em Cardiologia. Ed: Smetana R.Magnésio na saúde e na doença 274 John Libbey & Company Ltd., Londres, Reino Unido, pp. 415-421 (1997).
  46. Smetana, R: Medicina Cardiovascular - a importância de magnésio na doença arterial coronariana e agudo do miocárdio Infarte. In: Avanços na Pesquisa Magnésio: Magnésio em Cardiologia. Ed: Smetana R ,. John Libbey & Company Ltd., Londres, Reino Unido, pp. 5-11 (1997).
  47. Abraão, A, U. Eylath, H. & E. Weinstein Czaczkes: Níveis séricos de Mg em pacientes com infarto agudo do miocárdio. New Engl J Med 296, 862-863 1977.
  48. Pereira, JN, MJ Laires, A. França, A. Alcazar, R. Andrade, J. C. Rodrigues, P.P. Jacinto, T. Pereira, M. J. Halpern & J. Simões Fernandes: Hypomagnesemia e Coronária Doença isquêmica. Experiência de uma coronária de Acompanhamento Serviço. Na: Mg Deficiência. Fisiopatologia e Tratamento Implicações. Eds: Halpern, M. J. & J. Durlach, Karger, Basel, Alemanha, pp. 132-134 (1985)
  49. Shechter, H: O papel do magnésio como Terapia antitrombótica. In: Avanços em magnésio Pesquisa: Nutrição e Saúde. Eds: Rayssiguier, Y., A. Mazur & J. Durlach, John Libbey & Company Ltd., Londres, Reino Unido, pp. 333-340 (2001)
  50. Mata, KL, S. Fletcher, C. Roffe & Y. Haider: Sulfato de magnésio intravenoso em suspeita aguda infarto do miocárdio: resultados do segundo Leicester Estudo de intervenção de magnésio intravenoso (limite de 2). Lancet 339, 1553-1558 (1992).
  51. Reinhart, R., MD, Face; Marx Jr., James, PhD; Broste, S. K. MS; Haas, R. G., PhD — Myocardial Magnesium: Relation to Laboratory and Clinical Variables In Patients Undergoing Cardiac Surgery — J . Am. Coll. Cardiol. — 1991,17: 651-656.
  52. Touyz R.M., Schiffrin E.L. Reactive oxygen species in vascular biology: implacations in hypertension. Histochem Cell Biol 2004;122(4):339-52.
  53. Sheehan John, MD — Importance of Magnesium Chloride Repletion After Myocardial Infarction — The American Journal of Cardiology, vol. 63, April 18, (1989), 35G-38G.
  54. Rochette, I.; Norès, J. M.; Bril, A.; Remy, J. M. — Pathologie du magnésium — Cah. Nutr. Diet. — XXIII.5 (1988) 388-390.
  55. Seeling, Mildred, Md, MPH — Cardiovascular Consequences of Magnesium Dificiency and Loss: Pathogenesis, Prevalence and Manifestations — Magnesium and Chloride Loss in Refractory Potassium Repletion—The American Journal of Cardiology—vol. 63, April, 18,1989,04G-21G.
  56. Gottlieb, Stephen S. MD — Importance of Magnesium in congestive Heart Failure — The American Journal of Cardiology — vol. 63, April 18, 1989, 39G-42G.
  57. Shechter M., Sharir M., Labrador M.J., et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation.200;102(19):2353-8.
  58. Almoznino-Sarafian, D., Sarafian, G., Berman, S., Shteinshnaider, M., Tzur, I., Cohen, N., & Gorelik, O. (2009). Magnesium administration may improve heart rate variability in patients with heart failure. Nutrition, Metabolism and Cardiovascular Diseases, 19(9), 641-645.
  59. Guerrero-Romero F., Rodriguez-Moran M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J hum Hypertens. 2009;23(4):245-51
  60. Guerrero-Romero F., Tamez-Perez H.E., Gonzalez-Gonzalez G. et al. Oral magnesium supplementation improves insulin sensitivity in nom-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 2004;30(3):253-8.
  61. Lee S., Park H.K., Son S.P. et al. Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normomagnesemic nondiabetic overweight Korean adults. Nutr Metab Cardiovasc. Dis. 2009;19 (11):781-8.
  62. Giardina, B, M. Penco, G. Lazzarino, S. Romano, B. Tavazzi, F. Fedele, D. Di Pierro & A. Dagianti: Effectiveness of thrombolysis is associated with a timedependent increase of malondialdehyde in peripheral blood of patients with acute myocardial infarction. Am J Cardiol 71, 788-793 (1993).
  63. Tavazzi, B, G. Lazzarini, D. Di Pierro & B. Giardina: Malondialdehyde production and ascorbate decrease are associated to the reperfusion of the postischaemic rat heart. Free Radic Biol Med 13, 75-78 (1992)
  64. Koppel H, Gasser R, Spichiger U. [Free intracellular magnesium in myocardium–measurement and physiological role–state of the art]. Wien Med Wochenschr 2000;150:321-324.
  65. Woods KL, Fletcher S, Roffe C, et al. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992;339:1553-1558.
  66. Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1994;343:816-819.
  67. Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994). Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron, 12(3), 529-540.
  68. Woods KL: Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol 1991; 32: 3-10.
  69. White RE, Hartzell HC: Effects of intracellular free magnesium on calcium current in isolated cardiac myocites. Science 1988; 239: 778-780.
  70. Ferrari R, curello AS, Cecconi C: Myocardial recovery during post-ischaemic reperfusion: Effects of nifedipine, calcium,and magnesium. J Mol Cell Cardiol 1986; 18: 487-498.
  71. Herase DJ, stewart DA, bradimbirdge MV: Cellular protection during myocardial ischemia. Circulation 1976; 54: 193-202
  72. Juárez HU, Antman EM. El magnesio en el tratamiento del infarto agudo del miocardio. Revisión y controvérsias. Arch Cardiol Mex 2001; 71 (4)
  73. Volpe MA, Carneiro JJ; Luiz Alberto Magna LA; Viaro F; Origuela EAL, Evora PRB. -Disfunção Endotelial após Isquemia Global e Reperfusão em Cirurgia Cardíaca com Circulação Extracorpórea: Estudo do Papel do Magnésio em Artérias Coronarianas Caninas. Rev Bras Cir Cardiovasc 2002; 17(3): 187-200.
  74. Halpern, Manuel Júdice — Magnésio — Laboratórios Vitória.
  75. Rude, Robert K., MD — Physiology of Magnesium Metabolism and the Important Role of Magnesium in Potassium Deficiency — The American Journal of Cardiology — vol. 63, April 18,1989.31G-34G.
  76. Roden, Dan M., MD — Magnesium Treatment of Ventricular Arrhythmias — The American Journal of Cardiology — vol. 63, April 18,1989, 43G-46G.
  77. Gottlieb, S. S., MD, Face; Baruch, L, MD; Kurin, Marrick, MD, Face; Bernstein, J. L, MS; Fisher, M. L, MD, Face; Packer, Milton, MD, Face — Prognostic Importance of the Serum Magnesium Concentration in Patients With Congestiv Heart Failure — J. Am. Coll. Cardiol. — 1990,16:827- 831.
  78. Reinhart, Richard A., MD—Clinical correlates of the molecular and cellular actionsof magnesium on the cardiovascular system — American HeartJournal — May, 1991, vol, 121, 1513-1521.
  79. Tzivoni, Dan, MD; Keren, Audre, MD — Suppression of Ventricular Arrhythmias by Magnesium — The American Journal of Cardiology — June 1,1990, 1397-1399.
  80. De Oliveira Jr, G. S., Castro-Alves, L. J., Khan, J. H., & McCarthy, R. J. (2013). Perioperative systemic magnesium to minimize postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology, 119(1), 178-190.
  81. Peacock, J. M., Ohira, T., Post, W., Sotoodehnia, N., Rosamond, W., & Folsom, A. R. (2010). Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. American heart journal, 160(3), 464-470.
  82. Thomas, Anita J.; Bunker, Valda W.; Sodha, Nidish; Clayton, Barbara E. — Calcium, magnesium and phosphoros status of elderly inpatients: dietary intake metabolic balance studies and biochemical status — British Journal of Nutrition (1989) 62, 211-219.
  83. Shivakumar, K. (2001). Model of cardiovascular injury in magnesium deficiency. Medical hypotheses, 56(1), 110-113.
  84. Sherer, Y., Bitzur, R., Cohen, H., Shaish, A., Varon, D., Shoenfeld, Y., & Harats, D. (2001). Mechanisms of action of the anti-atherogenic effect of magnesium: lessons from a mouse model. Magnesium research: official organ of the International Society for the Development of Research on Magnesium, 14(3), 173-179.
  85. Durlach, J: Déficit magnésique, tétanie et dystonie neurovégétative: donnés nouvelles sur les formes neuromusculaires du déficit magnésique chronique. Magnesium Bull 3, 121-136 (1981).
  86. Goto, K., Yasne, H., MD; Okumura, Ken, MD; Matsuyama, K., MD; Kigiyama K., MD; Miyagi, H., MD; Higashi T., MD — Magnesium Dificiency detected by Intravenous Loading Test in Variant Angine Pectoris — The American Journal of Cardiology — March 15,1990, 709-712.
  87. Motoyama, Tkaaki; Sano, Hiroshi; Fukuzaki, Hisashi — Oral Magnesium Supplementation in Patients with Essencial Hypertension — Hypertension— vol. 13, NO 3, March 1989, 227232.
  88. Hatzistavri L.S., Sarafidis P.A., Georgianos P.I. et al. Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am J Hypertens. 2009;22(10):1070-5.
  89. Hollifield, John W., MD — Thiazid Treatment of Systemic Hypertension: Effects on Serum Magnesium and Ventricular Ectopic Activity —The American Journal of Cardiology—vol. 63 April 18, 1989, 31G-34G.
  90. Enciclopédia do Conhecimento (Ciência e Tecnologia, Vol. 3 A Química) — Resómnia Editores — pág. 40-41.
  91. Paolisso, G.; Sgambato, S.; Giuliano, D.; Toralla, R.; Varricchio, M.; Scheen, A. J.; D’Onofrio, F.; Lefebvre, P. J. — Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in Type 2 (non-insulin-dependent) diabetic patients — Diabetologia — (1988) 31: 910-915.
  92. Paolisso, G.; Massariello, N.; Pizza, G.; Marrazo, G.; Giunta., R.; Sgambato, S.; Varricchio, M; D’Onofrio, F.— Dietary magnesium supplements improve B-cell response to glucose and arginine in elderjy non-insulin dependent diabetic subjects — Acta Endocrinologia (Copenh) 1989,121,16-20.
  93. Resnick, Lawrence M., MD — Hypertension and Abnormal Glucose Homeostasis — TheAmerican Journal of Medicine — December 8, 1989, vol 87 (sup. 6-A), 6A-21S.
  94. Dyckner, T.; Hãgg, E.; Lithner, F.; Nyhlin, H.; Wester, P. O. — Muscle magnesium and capillarybasement membrane thickness in diabetes mellitus — Diabete & Métabolisme (Paris) 1988,14: 619-622.

How to Cite

Ramirez, A. V. G. (2022). A importância do magnésio na doença cardiovascular. International Journal of Nutrology, 9(4), 242–253. https://doi.org/10.1055/s-0040-1705639